Search
for
Sort by
Research 151–180 of 1000+
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Hair and Nail Manifestations of Systemic Disease
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Insulin Resistance Syndrome- the Sensitive IRS
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Vitex negundo: A comprehensive review of phytoconstituents, their derivatives, and therapeutic applications
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- The spectrum of nephrocutaneous diseases and associations
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Association Between Chlamydia trachomatis and Helicobacter pylori with Inflammation in Polycystic Ovary Syndrome: A Cross-Sectional Study
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- Hirsutism
- Biomedical applications of organoids in genetic diseases
- Testosterone: The Male Sex Hormone
- Loss of the Y Chromosome: A Review of Molecular Mechanisms, Age Inference, and Implications for Men’s Health
- A Review on PCOD: Polycystic Ovarian Disease
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- The good, the bad, and the ugly facets of insulin resistance
- The Multiple Consequences of Obesity
- Diagnosis and treatment of polycystic ovarian syndrome: an update
- Nutritional management in women with polycystic ovary syndrome: A review study
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women
- The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Cutaneous manifestations of metabolic diseases: uncommon presentations